Seroprevalence study using oral rapid HIV testing in a large urban Emergency Department

Sachin Jain, Erik S. Lowman, Adam Kessler, Jaime Harper, Dino P. Rumoro, Kimberly Y. Smith, Yanina Purim-Shem-Tov, Harold A. Kessler

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The Centers for Disease Control (CDC) recommends universal human immunodeficiency virus (HIV) testing for patients aged 13-64 years in health care settings where the seroprevalence is > 0.1%. Rapid HIV testing has several advantages; however, recent studies have raised concerns about false positives in populations with low seroprevalence. Study Objectives: To determine the seroprevalence of HIV in our Emergency Department (ED) population, understand patient preferences toward rapid testing in the ED, and evaluate the performance of a rapid oral HIV test. Methods: A serosurvey offered oral rapid HIV 1/2 testing (OraQuick ADVANCE, Bethlehem, PA) to a convenience sample of 1348 ED patients beginning August 2008. Subjects declining participation were asked to complete an opt-out survey. Results: 1000 patients were tested. Twelve had positive results (1.2%), including one who had newly diagnosed HIV infection; 988 patients tested negative. Of these, 335 (33.3%) had never been tested; 640 had prior history of a negative HIV test. No false-positive rapid HIV results were detected; 98.7% received the results of their preliminary HIV test, including 100% of those who tested positive. Most subjects who declined testing cited either a recent negative HIV test (160/348) or low perceived risk (65/348). A minority cited a concern regarding their privacy (11/348) or that the test might delay their treatment (7/348). Conclusions: The seroprevalence estimate of 1.2% was above the rate recommended by the CDC for routine universal opt-out testing in our study population. The acceptance rate of rapid HIV testing and the percentage of patients receiving results approximated other recent reports.

Original languageEnglish (US)
JournalJournal of Emergency Medicine
Volume43
Issue number5
DOIs
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Seroepidemiologic Studies
Hospital Emergency Service
HIV
Centers for Disease Control and Prevention (U.S.)
Population
HIV-2
Patient Preference
Privacy
Virus Diseases
HIV-1
Delivery of Health Care

Keywords

  • Emergency Department
  • HIV
  • oral
  • prevalence
  • rapid
  • test

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Jain, S., Lowman, E. S., Kessler, A., Harper, J., Rumoro, D. P., Smith, K. Y., ... Kessler, H. A. (2012). Seroprevalence study using oral rapid HIV testing in a large urban Emergency Department. Journal of Emergency Medicine, 43(5). https://doi.org/10.1016/j.jemermed.2012.02.021

Seroprevalence study using oral rapid HIV testing in a large urban Emergency Department. / Jain, Sachin; Lowman, Erik S.; Kessler, Adam; Harper, Jaime; Rumoro, Dino P.; Smith, Kimberly Y.; Purim-Shem-Tov, Yanina; Kessler, Harold A.

In: Journal of Emergency Medicine, Vol. 43, No. 5, 11.2012.

Research output: Contribution to journalArticle

Jain, S, Lowman, ES, Kessler, A, Harper, J, Rumoro, DP, Smith, KY, Purim-Shem-Tov, Y & Kessler, HA 2012, 'Seroprevalence study using oral rapid HIV testing in a large urban Emergency Department', Journal of Emergency Medicine, vol. 43, no. 5. https://doi.org/10.1016/j.jemermed.2012.02.021
Jain, Sachin ; Lowman, Erik S. ; Kessler, Adam ; Harper, Jaime ; Rumoro, Dino P. ; Smith, Kimberly Y. ; Purim-Shem-Tov, Yanina ; Kessler, Harold A. / Seroprevalence study using oral rapid HIV testing in a large urban Emergency Department. In: Journal of Emergency Medicine. 2012 ; Vol. 43, No. 5.
@article{810b47af13234f809ec5086fe849cba9,
title = "Seroprevalence study using oral rapid HIV testing in a large urban Emergency Department",
abstract = "Background: The Centers for Disease Control (CDC) recommends universal human immunodeficiency virus (HIV) testing for patients aged 13-64 years in health care settings where the seroprevalence is > 0.1{\%}. Rapid HIV testing has several advantages; however, recent studies have raised concerns about false positives in populations with low seroprevalence. Study Objectives: To determine the seroprevalence of HIV in our Emergency Department (ED) population, understand patient preferences toward rapid testing in the ED, and evaluate the performance of a rapid oral HIV test. Methods: A serosurvey offered oral rapid HIV 1/2 testing (OraQuick ADVANCE, Bethlehem, PA) to a convenience sample of 1348 ED patients beginning August 2008. Subjects declining participation were asked to complete an opt-out survey. Results: 1000 patients were tested. Twelve had positive results (1.2{\%}), including one who had newly diagnosed HIV infection; 988 patients tested negative. Of these, 335 (33.3{\%}) had never been tested; 640 had prior history of a negative HIV test. No false-positive rapid HIV results were detected; 98.7{\%} received the results of their preliminary HIV test, including 100{\%} of those who tested positive. Most subjects who declined testing cited either a recent negative HIV test (160/348) or low perceived risk (65/348). A minority cited a concern regarding their privacy (11/348) or that the test might delay their treatment (7/348). Conclusions: The seroprevalence estimate of 1.2{\%} was above the rate recommended by the CDC for routine universal opt-out testing in our study population. The acceptance rate of rapid HIV testing and the percentage of patients receiving results approximated other recent reports.",
keywords = "Emergency Department, HIV, oral, prevalence, rapid, test",
author = "Sachin Jain and Lowman, {Erik S.} and Adam Kessler and Jaime Harper and Rumoro, {Dino P.} and Smith, {Kimberly Y.} and Yanina Purim-Shem-Tov and Kessler, {Harold A.}",
year = "2012",
month = "11",
doi = "10.1016/j.jemermed.2012.02.021",
language = "English (US)",
volume = "43",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Seroprevalence study using oral rapid HIV testing in a large urban Emergency Department

AU - Jain, Sachin

AU - Lowman, Erik S.

AU - Kessler, Adam

AU - Harper, Jaime

AU - Rumoro, Dino P.

AU - Smith, Kimberly Y.

AU - Purim-Shem-Tov, Yanina

AU - Kessler, Harold A.

PY - 2012/11

Y1 - 2012/11

N2 - Background: The Centers for Disease Control (CDC) recommends universal human immunodeficiency virus (HIV) testing for patients aged 13-64 years in health care settings where the seroprevalence is > 0.1%. Rapid HIV testing has several advantages; however, recent studies have raised concerns about false positives in populations with low seroprevalence. Study Objectives: To determine the seroprevalence of HIV in our Emergency Department (ED) population, understand patient preferences toward rapid testing in the ED, and evaluate the performance of a rapid oral HIV test. Methods: A serosurvey offered oral rapid HIV 1/2 testing (OraQuick ADVANCE, Bethlehem, PA) to a convenience sample of 1348 ED patients beginning August 2008. Subjects declining participation were asked to complete an opt-out survey. Results: 1000 patients were tested. Twelve had positive results (1.2%), including one who had newly diagnosed HIV infection; 988 patients tested negative. Of these, 335 (33.3%) had never been tested; 640 had prior history of a negative HIV test. No false-positive rapid HIV results were detected; 98.7% received the results of their preliminary HIV test, including 100% of those who tested positive. Most subjects who declined testing cited either a recent negative HIV test (160/348) or low perceived risk (65/348). A minority cited a concern regarding their privacy (11/348) or that the test might delay their treatment (7/348). Conclusions: The seroprevalence estimate of 1.2% was above the rate recommended by the CDC for routine universal opt-out testing in our study population. The acceptance rate of rapid HIV testing and the percentage of patients receiving results approximated other recent reports.

AB - Background: The Centers for Disease Control (CDC) recommends universal human immunodeficiency virus (HIV) testing for patients aged 13-64 years in health care settings where the seroprevalence is > 0.1%. Rapid HIV testing has several advantages; however, recent studies have raised concerns about false positives in populations with low seroprevalence. Study Objectives: To determine the seroprevalence of HIV in our Emergency Department (ED) population, understand patient preferences toward rapid testing in the ED, and evaluate the performance of a rapid oral HIV test. Methods: A serosurvey offered oral rapid HIV 1/2 testing (OraQuick ADVANCE, Bethlehem, PA) to a convenience sample of 1348 ED patients beginning August 2008. Subjects declining participation were asked to complete an opt-out survey. Results: 1000 patients were tested. Twelve had positive results (1.2%), including one who had newly diagnosed HIV infection; 988 patients tested negative. Of these, 335 (33.3%) had never been tested; 640 had prior history of a negative HIV test. No false-positive rapid HIV results were detected; 98.7% received the results of their preliminary HIV test, including 100% of those who tested positive. Most subjects who declined testing cited either a recent negative HIV test (160/348) or low perceived risk (65/348). A minority cited a concern regarding their privacy (11/348) or that the test might delay their treatment (7/348). Conclusions: The seroprevalence estimate of 1.2% was above the rate recommended by the CDC for routine universal opt-out testing in our study population. The acceptance rate of rapid HIV testing and the percentage of patients receiving results approximated other recent reports.

KW - Emergency Department

KW - HIV

KW - oral

KW - prevalence

KW - rapid

KW - test

UR - http://www.scopus.com/inward/record.url?scp=84869085663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869085663&partnerID=8YFLogxK

U2 - 10.1016/j.jemermed.2012.02.021

DO - 10.1016/j.jemermed.2012.02.021

M3 - Article

VL - 43

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

IS - 5

ER -